14 Aug 2026, 3:34 pmCompany Update
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication PDF
Loading page…
Johnson Pharmacare Ltd operates in Diversified Commercial Services within the Industrials sector.
Beta is measured against NIFTY 50 over three years of weekly returns — 1 moves with the index, above 1 amplifies it, below 1 damps it.
No positive flags triggered.
Structured signal from quality, growth, valuation and momentum.
₹ crore, by fiscal year
% of revenue, by fiscal year
Comparable companies from the narrowest available industry classification.
Reported profit and loss, balance sheet, cash flow and growth history.
Annual operating, return, leverage and working-capital ratios.
Current futures and options contracts with compact option-chain pages.
Mutual-fund schemes that disclosed a holding in the company.
Annual reports, exchange filings, offer documents, ratings and earnings-call material.
Upcoming dates and the company’s corporate-action history.
Latest exchange announcements, filings and downloadable documents.
Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.
No scheme among the 32 fund houses on record reported a position in Johnson Pharmacare Ltd. Portfolios are published monthly by each AMC; coverage is still partial.
| Company | Mkt Cap | EV | Revenue | EBITDA | OPM | PAT | NPM | ROCE | ROE | WC Days |
|---|---|---|---|---|---|---|---|---|---|---|
| International Gemological Institute LimitedIGILIGIL | ₹13,482 Cr | ₹13,482 Cr | ₹1,363 Cr | ₹827 Cr | 60.9% | ₹610 Cr | 44.5% | 61.1% | 49.1% | 36 |
| Wework India Management LimitedWEWORKWEWORK | ₹8,931 Cr | ₹9,264 Cr | ₹2,589 Cr | ₹1,676 Cr | 64.5% | ₹84 Cr | 3.1% | 12.4% | 25% | -18 |
| Nesco LimitedNESCONESCO | ₹7,249 Cr | ₹7,249 Cr | ₹951 Cr | ₹482 Cr | 52.6% | ₹417 Cr | 44.3% | 17% | 14.7% | 1 |
| Indiabulls LimitedIBULLSLTDIBULLSLTD | ₹6,856 Cr | ₹7,314 Cr | ₹1,101 Cr | ₹417 Cr | 33.2% | ₹419 Cr | 41.5% | — | 8.9% | — |
| Inox Green Energy Services LimitedINOXGREENINOXGREEN | ₹6,384 Cr | ₹6,472 Cr | ₹280 Cr | ₹28 Cr | 8.2% | ₹121 Cr | 36.8% | 8.5% | 5.6% | 405 |
| Leap India LimitedLEAPINDLEAPIND | ₹6,036 Cr | ₹7,054 Cr | ₹730 Cr | ₹157 Cr | 21.5% | ₹62 Cr | 8.6% | 9.5% | 9.6% | -520 |
| Smartworks Coworking Spaces LimitedSMARTWORKSSMARTWORKS | ₹5,837 Cr | ₹6,044 Cr | ₹1,963 Cr | ₹1,260 Cr | 64.3% | ₹28 Cr | 0.6% | 7.5% | 2% | -102 |
| Elevate Campuses LimitedELEVATEELEVATE | ₹5,811 Cr | ₹9,931 Cr | ₹569 Cr | ₹405 Cr | 71.3% | ₹174 Cr | 30.6% | 9.3% | 21.1% | — |
| Nirlon LimitedNIRLONNIRLON | ₹5,467 Cr | ₹6,614 Cr | ₹317 Cr | ₹237 Cr | 79.1% | ₹127 Cr | 34.3% | 23.2% | 59.8% | -56 |
| Quess Corp LimitedQUESSQUESS | ₹5,023 Cr | ₹5,023 Cr | ₹15,835 Cr | ₹327 Cr | 2% | ₹253 Cr | 1.5% | 19.2% | 19.7% | 19 |
| Indiqube Spaces LimitedINDIQUBEINDIQUBE | ₹4,187 Cr | ₹4,477 Cr | ₹1,564 Cr | ₹952 Cr | 60.8% | ₹-93 Cr | -7.3% | 5.7% | -20.7% | -273 |
| Sanghvi Movers LimitedSANGHVIMOVSANGHVIMOV | ₹3,719 Cr | ₹4,393 Cr | ₹1,177 Cr | ₹426 Cr | 37.4% | ₹199 Cr | 17.2% | 18% | 15% | 77 |
Standalone figures
| Ratio | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Margins | ||||||||
| Gross margin % | — | — | 14.5% | 17.5% | 20.2% | — | — | — |
| EBITDA margin % | — | — | 0% | 4% | 9.1% | — | — | — |
| EBIT margin % | — | — | 0% | 4% | 9.1% | — | — | — |
| PAT margin % | — | — | 0% | 3.1% | -51% | — | — | — |
| Working capital | ||||||||
| Receivable days | — | — | 807 | 118 | 0 | — | — | — |
| Inventory days | — | — | 0 | 0 | 0 | — | — | — |
| Payable days | — | — | 365 | 0 | 0 | — | — | — |
| NWC days | — | — | 442 | 118 | 0 | — | — | — |
| Leverage | ||||||||
| Current ratio | — | — | 8.62 | 3.7 | 14.56 | 0 | 1.18 | 12.16 |
| Debt to EBITDA | — | — | — | 4.69 | 8.3 | — | — | — |
| Debt to equity | — | — | 0.01 | 0.01 | 0.03 | 0.03 | 0.01 | 48.64 |
| Interest coverage | — | — | — | — | — | — | — | -158.5 |
| Asset turnover | — | — | 0.01 | 0.05 | 0.04 | — | — | 0 |
| Return ratios | ||||||||
| Return on assets % | — | — | 0% | 0.2% | -2.2% | -0.3% | -1% | -253% |
| Return on capital employed % | — | — | 0% | 0.2% | -2.2% | 0% | 0% | -104.8% |
| Return on equity % | — | — | 0% | 0.2% | -2.3% | -0.4% | -1% | -12,665.9% |
Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.
Documents link to external sources (exchange filings, company investor pages).
| Holder (%) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DII | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | |
| No. of shareholders | — | — | — | — | — | — | — | — | 1,17,101 | 1,17,101 | 1,17,101 | 1,17,101 |
Promoter holding up 0 percentage points since Sep 2023.
| Date | Client | Type | Venue | Side | Quantity | Price | Value |
|---|---|---|---|---|---|---|---|
| 5 Jul 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Sell | 67,77,253 | ₹1.19 | ₹0.81 Cr |
| 5 Jul 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Sell | 54,95,207 | ₹1.20 | ₹0.66 Cr |
| 5 Jul 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Buy | 3,00,000 | ₹1.19 | ₹0.04 Cr |
| 4 Jul 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Buy | 27,77,253 | ₹1.15 | ₹0.32 Cr |
| 4 Jul 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Sell | 38,463 | ₹1.15 | ₹0.00 Cr |
| 27 Jun 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Buy | 50,37,152 | ₹0.95 | ₹0.48 Cr |
| 27 Jun 2024 | MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Bulk | BSE | Sell | 45,85,505 | ₹0.95 | ₹0.44 Cr |
| 19 Jan 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Sell | 30,00,000 | ₹0.98 | ₹0.29 Cr |
| 18 Jan 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Buy | 30,00,000 | ₹1.00 | ₹0.30 Cr |
| 18 Jan 2024 | TOPGAIN FINANCE PRIVATE LIMITED | Bulk | BSE | Sell | 5,44,816 | ₹1.02 | ₹0.06 Cr |
Current officeholders as filed with BSE. A person holding two offices is listed once per office.
Announcement under Regulation 30 (LODR)-Newspaper Publication
Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On June 30Th, 2026.
Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th, 2026 And Along With Limited Review Report Thereon.
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday, 13Th August, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June, 2026.
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| Date | Category | Subject | Filing |
|---|---|---|---|
| 14 Aug 2026, 3:34 pm | Company Update Newspaper Publication | Announcement under Regulation 30 (LODR)-Newspaper Publication | |
| 13 Aug 2026, 7:28 pm | Company Update Reg. 32 (1), (3) - Statement of Deviation & Variation | Undertaking For Non- Applicability Of Regulation 32 Of SEBI (LODR) Regulations, 2015 For The Quarter Ended On June 30Th, 2026. |
Bulk deals are a client trading over 0.5% of the equity in a session, aggregated across their trades; block deals are single negotiated trades in the exchange’s block window. Each is reported by the exchange it was crossed on, so NSE and BSE rows are separate trades rather than the same trade twice.
| 13 Aug 2026, 7:21 pm | Result Financial Results | Submission Of Un-Audited Financial Results Of (JOHNSON PHARMACARE LTD) For The Quarter Ended On June 30Th, 2026 And Along With Limited Review Report Thereon. |
| 13 Aug 2026, 7:12 pm | Board Meeting Outcome of Board Meeting | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Held On Thursday, 13Th August, 2026 At Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015. |
| 11 Aug 2026, 8:52 pm | Company Update Change in Registered Office Address | Announcement under Regulation 30 (LODR)-Change in Registered Office Address |
| 8 Aug 2026, 7:12 pm | Board Meeting | Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June, 2026. |
| 13 Jul 2026, 4:42 pm | Company Update Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| ₹ Cr | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | 1 | 3 | 3 | — | — | 0 | |
| COGS | — | — | — | — | — | 1 | 3 | 2 | — | — | 0 |
| Gross profit | — | — | — | — | — | 0 | 1 | 1 | — | — | — |
| — | — | — | — | — | 0 | 0 | 0 | — | — | 43 | |
| — | — | — | — | — | 0 | 0 | 0 | — | — | -43 | |
| OPM % | — | — | — | — | — | 0% | 4% | 9.1% | — | — | — |
| Depreciation | — | — | — | — | — | 0 | 0 | 0 | — | — | 0 |
| Interest | — | — | — | — | — | 0 | 0 | 0 | — | — | 0 |
| — | — | — | — | — | 0 | 0 | -2 | — | — | -13 | |
| Profit before tax | -0 | -0 | -0 | -0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 |
| Tax | — | — | — | — | — | 0 | 0 | 0 | — | — | 0 |
| Tax % | — | — | — | — | — | — | 30.8% | 0% | — | — | 0% |
| -0 | -0 | -0 | -0 | -0 | 0 | 0 | -1 | -0 | -1 | -56 | |
| PAT margin % | — | — | — | — | — | 0% | 3.1% | -51% | — | — | — |
| EPS (₹) | — | — | — | — | — | 0 | 0 | -0 | — | — | -1 |
| EPS adjusted (₹) | — | — | — | — | — | 0 | 0 | -0 | -0 | -0 | -1 |
| Annual report | Annual report for Mar 2016 | Annual report for Mar 2017 | Annual report for Mar 2018 | Annual report for Mar 2019 | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 50 | 55 | 55 | 55 | 55 | 55 |
| Reserves | 8 | 3 | 2 | 2 | 1 | -55 |
| 1 | 1 | 2 | 2 | 1 | 21 | |
| 1 | 1 | 1 | 1 | 1 | 0 | |
| Total equity & liabilities | 59 | 60 | 60 | 60 | 58 | 22 |
| 0 | 0 | 0 | — | — | 0 | |
| CWIP | 0 | 0 | 0 | — | — | — |
| Investments | 52 | 54 | 46 | 46 | 42 | 20 |
| 7 | 6 | 14 | 14 | 16 | 2 | |
| Total assets | 59 | 60 | 60 | 60 | 58 | 22 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| -0 | 2 | -12 | 0 | 2 | -58 | |
| 0 | -2 | 10 | -0 | -3 | 37 | |
| 0 | -0 | 1 | 0 | 1 | 21 | |
| Net cash flow | -0 | -0 | -0 | 0 | 0 | 0 |
| Free cash flow | -0 | 2 | -12 | — | — | -58 |
| CFO / Operating profit % | — | — | — | — | — | — |